{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:40:02Z","timestamp":1792766402753,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.tcm.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T11:09:15Z","timestamp":1567595355000},"page":"399-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":352,"title":["Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-4356","authenticated-orcid":false,"given":"Olatokunbo","family":"Osibogun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluseye","family":"Ogunmoroti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-5084","authenticated-orcid":false,"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","article-title":"Polycystic ovarian syndrome","volume":"99","author":"Trikudanathan","year":"2015","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.tcm.2019.08.010_bib0003","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"Polycystic Ovarian Syndrome: Long-Term Health Consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.tcm.2019.08.010_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.tcm.2019.08.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02496","article-title":"Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome","author":"Dapas","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tcm.2019.08.010_bib0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0008","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"23","key":"10.1016\/j.tcm.2019.08.010_bib0009","doi-asserted-by":"crossref","first-page":"33715","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.tcm.2019.08.010_bib0010","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.tcm.2019.08.010_bib0011","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"11","key":"10.1016\/j.tcm.2019.08.010_bib0012","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/jwh.2018.7162","article-title":"Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?","volume":"27","author":"Carmina","year":"2018","journal-title":"J Women's Health (2002)"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0013","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertility Sterility"},{"issue":"7","key":"10.1016\/j.tcm.2019.08.010_bib0014","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.tcm.2019.08.010_bib0015","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2019.08.010_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.tcm.2019.08.010_bib0017","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2013a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tcm.2019.08.010_bib0018","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.tcm.2019.08.010_bib0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/dc18-1738","article-title":"The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome","volume":"42","author":"Kakoly","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.fertnstert.2018.11.034","article-title":"ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome","volume":"111","author":"Marchesan","year":"2019","journal-title":"Fertility Sterility"},{"issue":"7","key":"10.1016\/j.tcm.2019.08.010_bib0021","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.tcm.2019.08.010_bib0022","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/jc.2006-0399","article-title":"Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome","volume":"91","author":"Cascella","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/obe.2007.0019","article-title":"Obesity and Polycystic Ovary Syndrome","volume":"3","author":"Sam","year":"2007","journal-title":"Obes Manag"},{"issue":"6","key":"10.1016\/j.tcm.2019.08.010_bib0024","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.tcm.2019.08.010_bib0025","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.fertnstert.2008.09.003","article-title":"Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women","volume":"92","author":"Liou","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.fertnstert.2018.11.001","article-title":"Does body weight affect cardiometabolic risk in women with polycystic ovary syndrome?","volume":"111","author":"Dokras","year":"2019","journal-title":"Fertil Steril."},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0027","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.mce.2009.09.026","article-title":"Ovarian function and obesity\u2013interrelationship, impact on women's reproductive lifespan and treatment options","volume":"316","author":"Rachon","year":"2010","journal-title":"Molec Cell Endocrinol"},{"issue":"17","key":"10.1016\/j.tcm.2019.08.010_bib0028","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0029","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"50","author":"Essah","year":"2007","journal-title":"Clin Obstetr Gynecol"},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obesity Rev"},{"issue":"6","key":"10.1016\/j.tcm.2019.08.010_bib0031","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.tcm.2019.08.010_bib0032","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.2010.03907.x","article-title":"Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study","volume":"74","author":"Chang","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0034","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Meyer","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12291-008-0059-6","article-title":"Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome","volume":"23","author":"Saha","year":"2008","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"10.1016\/j.tcm.2019.08.010_bib0036","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.tcm.2019.08.010_bib0037","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.tcm.2019.08.010_bib0038","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.tcm.2019.08.010_bib0039","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","article-title":"Inflammatory and endothelial markers in women with polycystic ovary syndrome","volume":"36","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tcm.2019.08.010_bib0041","first-page":"74","article-title":"Risk of cardiovascular events in patients with polycystic ovary syndrome","volume":"70","author":"Iftikhar","year":"2012","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.tcm.2019.08.010_bib0042","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tcm.2019.08.010_bib0043","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.tcm.2019.08.010_bib0044","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/humrep\/del306","article-title":"Is the PCOS diagnosis solved by ESHRE\/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?","volume":"21","author":"Belosi","year":"2006","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.tcm.2019.08.010_bib0045","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/humrep\/dep121","article-title":"Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype","volume":"24","author":"Rizzo","year":"2009","journal-title":"Hum Reprod"},{"issue":"4 Suppl","key":"10.1016\/j.tcm.2019.08.010_bib0046","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2008.03.007","article-title":"Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome","volume":"91","author":"Carmina","year":"2009","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.tcm.2019.08.010_bib0047","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tcm.2019.08.010_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol."}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819301288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819301288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:59:53Z","timestamp":1760936393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173819301288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1050173819301288"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2019.08.010","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}